Please login to the form below

Not currently logged in
Email:
Password:

STING

This page shows the latest STING news and features for those working in and with pharma, biotech and healthcare.

Merck KGaA and Mersana partner in potential $830m deal

Merck KGaA and Mersana partner in potential $830m deal

Mersana’s proprietary Immunosynthen STING-agonist ADC platform generates systemically administered ADCs that locally activate STING signalling in both tumour-resident immune cells and antigen-expressing tumour cells, unlocking the ... This

Latest news

More from news
Approximately 2 fully matching, plus 20 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Genesis Research

Genesis Research is an international HEOR and RWE research organization. A leader in evidence strategy, generation and communication, the company...

Latest intelligence

Whitepaper: Closing the gap with compelling healthcare communications
Want to learn how to close the distance between a person’s current health and their healthiest possible self?...
Healing the Healers
Because if we do not heal the healers, who is going to heal us?...
The (inevitable) digital transformation of Medical Affairs
It’s not a question of ‘if,’ it’s a question of ‘when.’...